Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
J Invest Dermatol ; 104(6): 902-9, 1995 Jun.
Article in English | MEDLINE | ID: mdl-7769256

ABSTRACT

Loricrin, involucrin, small proline-rich protein (SPRR)1, SPRR2, and SPRR3 genes are located within a cluster of 1.5 Mbp on chromosome 1q21 and most likely evolved from a common ancestor. Monospecific polyclonal antibodies and cDNA probes were produced to investigate SPRR transcripts and proteins. SPRR expression was restricted to terminally differentiating squamous cells, preferentially located at the cell periphery, and immunoreactivity was greatly reduced in cells with a mature cornified cell envelope. Furthermore, detectable SPRR2 and SPRR3 levels were strongly increased in differentiating keratinocyte cultures after addition of LTB-2, a specific inhibitor of transglutaminases, suggesting that they are precursor proteins of the cornified cell envelope. In normal epidermis, SPRR1 was restricted to appendageal areas, SPRR2 was expressed coherently, and SPRR3 was completely absent. In the upper digestive tract, SPRR1 was expressed in sublingual and tongue epithelium, SPRR2 was mostly restricted to lingual papillae, and SPRR3 was abundant in oral and esophageal epithelium. In psoriatic epidermis, SPRR1 and SPRR2 were expressed at much higher levels than in normal epidermis. Addition of 10(-7) M retinoic acid to cultured differentiating keratinocytes significantly down-regulated the expression of SPRR2 and SPRR3 transcripts and slightly decreased that of SPRR1. Thus, SPRR1, SPRR2, and SPRR3 are differentially expressed in vivo and in vitro, suggesting that the SPRR multigene family evolved to serve as highly specialized cornified cell envelope precursor proteins in stratified epithelia.


Subject(s)
Proteins/analysis , Alleles , Amino Acid Sequence , Antibody Specificity , Cornified Envelope Proline-Rich Proteins , Humans , Keratinocytes/metabolism , Membrane Proteins/analysis , Membrane Proteins/genetics , Molecular Sequence Data , Polymorphism, Genetic , Protein Precursors/analysis , Protein Precursors/genetics , Proteins/genetics , Proteins/immunology , Transcription, Genetic , Transglutaminases/antagonists & inhibitors , Transglutaminases/physiology
2.
Biochemistry ; 30(4): 1080-5, 1991 Jan 29.
Article in English | MEDLINE | ID: mdl-1703437

ABSTRACT

The third component of human complement (C3) is a key molecule in the activation of the complement cascade. C3 cDNA fragments were used to identify seven cosmid clones that covered all but 1 kilobase pair (kb) of the C3 gene. The remainder of the gene was cloned by using the polymerase chain reaction. These clones were used to identify the intron/exon boundaries and to map the gene. The C3 gene is 42 kb in length and comprises 41 exons ranging in size from 52 to 213 base pairs (bp). The transcription start site was identified by primer extension, and approximately 1 kb of DNA upstream of this site was sequenced. Putative TATA and CAAT boxes were identified along with a number of regions that shared homology with known regulatory sequences. These include responsive elements for interferon-gamma, interleukin-6, nuclear factor kappa B, estrogen, glucocorticoids and thyroid hormone. Several of these agents have been shown to affect C3 synthesis and mRNA levels. The sizes of the exons in C3 were compared to those of C4 and alpha 2-macroglobulin (alpha 2M). Thirty-nine of 41 exons in C4 were found to be of similar size to the analogous ones in C3, and two-thirds of those in alpha 2M were also similarly sized, supporting the hypothesis that these genes arose from a common ancestor.


Subject(s)
Complement C3/genetics , Exons , Introns , Promoter Regions, Genetic , Amino Acid Sequence , Base Sequence , Biological Evolution , Biological Factors/pharmacology , Complement C3/biosynthesis , DNA/chemistry , Hormones/pharmacology , Humans , Molecular Sequence Data , RNA, Messenger/metabolism , Sequence Homology, Nucleic Acid , Structure-Activity Relationship , TATA Box , Transcription, Genetic , alpha-Macroglobulins/biosynthesis , alpha-Macroglobulins/genetics
3.
J Biol Chem ; 264(15): 8471-4, 1989 May 25.
Article in English | MEDLINE | ID: mdl-2722781

ABSTRACT

The third component of human complement (C3), a central molecule in both the classical and alternative pathways of complement, is comprised of two polypeptides, termed the alpha and beta chains. Activation of C3 cleaves the alpha chain into two fragments, C3a, an inflammatory peptide, and the alpha' chain which remains covalently linked to the beta chain. Proteolytic fragments derived from the alpha' chain during activation and regulation of complement play a significant role in host defense and regulation of the immune response. Two cosmid clones covering the alpha' chain region were used to characterize the structure of this portion of the C3 gene. The alpha' chain is encoded by 24 exons, which range in size from 52 to 213 base pairs (bp) with an average size of 115 bp. The splice donor sequence at the beginning of intron 12 has a rare sequence variant of GC instead of the usual GT sequence. Ten introns have been completely sequenced and were surprisingly short, ranging in size from 85 to 242 bp with an average of 140 bp. Other introns range in size from 250 bp to over 4 kilobases in length. The gene size for this portion of C3 is estimated to be 23-24 kilobases. Comparison of exon structure with protein domains and with peptide mapping studies demonstrates that several binding sites on C3 are encoded by single exons. These data support the hypothesis that individual exons can code for functional protein domains.


Subject(s)
Complement C3/genetics , DNA/genetics , Exons , Genes , Introns , Base Sequence , Cosmids , Female , Humans , Molecular Sequence Data , Placenta/metabolism , Pregnancy
SELECTION OF CITATIONS
SEARCH DETAIL
...